Biossil

Toronto, Canada · Founded 2023 · Privately Held (backing)

Developer of an artificial intelligence drug discovery platform designed to offer targeted therapies for biologically defined patient sub-populations. Biossil is based in Toronto, Canada and was founded in 2023. It has raised $12.4 million.

Last price · $/share
—
Implied valuation
—
Total raised
$12.4M
Last round
—
Valuation — not yet established

No valuation for Biossil is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($12.4M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Biossil with a free account
  • ·Watch Biossil: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Biossil funding history

No rounds on record

No funding rounds for Biossil are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How Biossil's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Biossil, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Biossil

How much has Biossil raised?
Biossil has raised $12.4M in total funding across its recorded rounds.